A startup’s psychedelic delivery tech is grabbing attention. Will pharma listen?
PharmaVoice
SEPTEMBER 1, 2023
Psycheceutical is developing a back-of-the-neck topical treatment for ketamine but believes the delivery route holds promise for far more drugs.
Let's personalize your content